Full Text View
Tabular View
No Study Results Posted
Related Studies
Video Support Program For Families With a Parent Newly Diagnosed With Cancer
This study is ongoing, but not recruiting participants.
Study NCT00020553   Information provided by National Cancer Institute (NCI)
First Received: July 11, 2001   Last Updated: July 20, 2009   History of Changes

July 11, 2001
July 20, 2009
August 2000
 
 
 
Complete list of historical versions of study NCT00020553 on ClinicalTrials.gov Archive Site
 
 
 
Video Support Program For Families With a Parent Newly Diagnosed With Cancer
We Can Cope: Family Support When A Parent Has Cancer

RATIONALE: A videotape support program may help families improve communication and coping skills when a parent is diagnosed with cancer.

PURPOSE: Randomized trial to study the effectiveness of a video support program for families who have a parent who has been newly diagnosed with cancer.

OBJECTIVES: I. Determine if families who participate in a video support program function better as a family in the areas of communication, togetherness, and overall increased ability to cope when a parent is newly diagnosed with cancer. II. Determine if participation in this program decreases stress-related illness in the well members of the family. III. Determine the safety of this program. IV. Determine patient/family and medical provider satisfaction with this program.

OUTLINE: This a randomized study. Adult parent participants and spouses undergo a baseline assessment over approximately 1 hour comprising completion of a self-assessment form followed by an interview. Families are then randomized to one of two arms. Arm I: Adult parent participants receive a video support program comprising 3 videotapes (parent tape, adolescent tape, and child tape) and a parent guidebook. The parents are encouraged to screen the videotapes and decide whether to have their child and/or adolescent view the program. Arm II: Adult parent participants receive no video support material. Families may view the video program after study completion. Adult parent participants in both arms complete follow-up assessments at 6 and 12 weeks. This clinical trial is being conducted at the locations listed below. If you are interested in this clinical trial but unable to visit these locations, please call #1-800-848-3895 ext. 226 and ask for more information about the We Can Cope study.

PROJECTED ACCRUAL: A total of 230 families will be accrued for this study.

 
Interventional
Other
Psychosocial Effects of Cancer and Its Treatment
Procedure: psychosocial assessment and care
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Active, not recruiting
 
 
 

DISEASE CHARACTERISTICS: Parent with a first diagnosis of cancer within the past 5 years No recurrence of a previously diagnosed cancer Must have at least 1 child between the ages of 6 and 18 Ill parent must live with child/children at least 50% of the time No plans to move out-of-state within the next 3 months

PATIENT CHARACTERISTICS: Age: See Disease Characteristics Any age Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Other: No psychotic disorder (such as schizophrenia) or a brain/psychiatric disorder due to disease/illness

PRIOR CONCURRENT THERAPY: Not specified

Both
 
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00020553
 
CDR0000068602, INFLEXXION-000080, ITS-000080, NCI-V01-1659
Inflexxion
National Cancer Institute (NCI)
Study Chair: Jonas I. Bromberg Inflexxion
National Cancer Institute (NCI)
October 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP